Neuropsychiatric Adverse Events During 12 Months of Treatment With Efavirenz in Treatment-Naïve HIV-Infected Patients in China: A Prospective Cohort Study

Background: Efavirenz (EFV) is widely used in antiretroviral therapy (ART), but the incidence and risk factors of neuropsychiatric adverse events (NPAEs) after EFV treatment have rarely been studied in Chinese ART naïve patients. Methods: This prospective cohort study assessed HIV-infected patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Hua, Wei, Wang, Sen, Wang, Xi, Shao, Ying, Wang, Yali, Ye, Jiangzhu, Su, Bin, Jiang, Taiyi, Zhang, Tong, Wu, Hao, Liu, An, Li, Qunhui, Mahajan, Supriya D., Li, Zaicun, Sun, Lijun, Dai, Lili
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943719/
https://www.ncbi.nlm.nih.gov/pubmed/33716807
http://dx.doi.org/10.3389/fpsyt.2021.579448

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7943719/
https://www.ncbi.nlm.nih.gov/pubmed/33716807
http://dx.doi.org/10.3389/fpsyt.2021.579448

Ejemplares similares